Ekso Bionics Holdings, Inc.

EKSO • NASDAQ

Ekso Bionics Holdings, Inc. is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Scott G. Davis, with a market cap of $32.1M.

Market Cap$32.1M

Employees72.0

CEOScott G. Davis

CountryUnited States of America

Healthcare

Medical - Instruments & Supplies

Next EarningsMay 4, 2026 · In 2 weeksAfter Market Close · Q1 2026

Income Statement Balance Sheet Cash Flow Business Segments

Financials

View all metrics

Ekso Bionics Holdings, Inc. FAQ

Common questions about Ekso Bionics Holdings, Inc.

Ekso Bionics Holdings, Inc. is scheduled to report earnings for Q1 2026 on May 4, 2026 after market close. Analysts estimate revenue of $4.5M.

Ekso Bionics Holdings, Inc. has approximately 72 employees.

Ekso Bionics Holdings, Inc.

Financials

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Ekso Bionics Holdings, Inc. FAQ

When is Ekso Bionics Holdings, Inc.'s next earnings date?

How many employees does Ekso Bionics Holdings, Inc. have?

Cookie Preferences